SLC37A4 and metabolic syndrome: The importance of the G6PT-H6PDH-11β-HSD1 system in the ER-lumen received a distinct focus in the past few years, providing a novel pharmaceutical potential to intervene in the progression of MetS and prevent its diabetic and cardiovascular consequences.